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Abstract 
Chiral and achiral allyltrichlorostannanes reacted with chiral aldehydes to give the corresponding 
homoallylic alcohols with good to high diastereoselectivities. This approach has been applied to 
the synthesis of hydroxyethylene dipeptide isosteres L-682, 679, L-684,414, L-685,434 and L-
685,458. 
 






The Lewis-acid mediated reaction of allylsilanes and allylstannanes with aldehydes is a well-
known procedure for the preparation of homoallylic alcohols.1,2 The stereochemical outcome of 
this reaction has on occasion been explained by considering Lewis acid-carbonyl complexation. 
This type of complexation mainly occurs by two discrete pathways, chelation and non-chelation 
controlled, depending on the nature of the Lewis acid and on the steric requirements of the 
carbonyl ligand. Condensation of allylic metals (e.g M: Si, Ti, Sn. B, Cr) with various carbonyl 
compounds can be used to achieve acyclic stereoselection, and has been applied to the synthesis 
of natural products.3,4 Chiral allylmetal reagents may be thought of as acetate-enolate equivalents 
for diastereoselective construction of stereochemically well-defined homoallylic alcohols. As 
these reactions complement the aldol reactions, allylsilanes and allylstannanes are among the 
most important groups of organometallic type reagents available for the control of acyclic 
stereochemistry.1,4 Many methods can be used to control the configurations of stereogenic 
centers that are close to each other. However, relatively few methods are available for control of 
the stereochemistry of more remote stereocenters. 
ISSN 1551-7012 Page 240 ©ARKAT USA, Inc 
 
Issue in Honor of Prof. R. Rossi and Prof. E. Rúveda ARKIVOC 2003 (x) 240-261 
This account focuses on our recent work on the chemistry of allylsilanes and 
allyltrichlorostannanes. We believe this chemistry may be very useful for the synthesis of 
compounds with remote stereogenic centers and is reviewed in this article. 
 
NMR study on ligand exchange reactions between allylsilanes and SnCl4
We began this work a few years ago, with a spectroscopic study (1H, 13C, and 119Sn NMR) of the 
reactions of allylsilanes 1, 3 and 5 with SnCl4 (Scheme 1).5,6 Allylsilanes 1, 3 and 5 and SnCl4 
(0.5 M solution in CDCl3) were mixed in order to promote ligand exchange, leading to the 

































For allyltrimethylsilane 1 the ligand exchange producing allyltrichlorostannane 2 and 
Me3SiCl is complete after 120 minutes at room temperature (Scheme 1). For allylsilane 3 the 
metathesis to give 4 and Me3SiCl is faster, as expected for a 1,1-disubstituted olefin, being 
complete after 60 minutes at room temperature.6 Upon addition of SnCl4 to a solution of 
allylsilane (S)-5 in CDCl3, at −60 oC, as well as at room temperature, a slightly yellow 
homogeneous solution was obtained. The resulting NMR spectrum at −60 oC showed formation 
of Me3SiCl and complete consumption of the allylsilane (S)-5 within 1 minute to give 
allyltrichlorostannane (S)-6. It appears that the oxygen functionality is responsible for the rapid 
ligand exchange reaction observed even at low temperatures for this particular allylsilane and 
SnCl4. The ligand exchange reaction is probably facilitated by coordination of tin to this oxygen 
followed by cleavage of the carbon-silicon bond by a free chloride ion.  
Most diagnostics is the deshielding of the hydrogens H1 to H6 in the 1H NMR spectrum of 
(S)-6 (Figure 1). The methylenic hydrogens H3 and H4 as well as the benzylic hydrogens H5 and 
H6 are too far away from trichlorotin group to suffer from inductive effects. We believe that the 
deshielding observed for these hydrogens is due to the internal coordination of this oxygen to tin, 
as proposed in Figure 1.6
ISSN 1551-7012 Page 241 ©ARKAT USA, Inc 
 































Analysis of the 13C NMR spectrum showed a deshielding for most carbons of (S)-6 when 
compared to allylsilane (S)-5 (Figure 2).  Most diagnostic is the chemical shift of 39.95 ppm for 
the carbon attached to tin in the new species, compared to 26.63 ppm for the same carbon in the 


















The 13C NMR spectra proved less useful than the 1H NMR spectra in establishing 
complexation to the benzyl oxygen, as there was no significant difference between the chemical 
shifts for methylenic carbons in both species.  
We have observed 119Sn resonance signals at −27 ppm for allylstannanes 2 and 4.6 The tin 
chemical shift for allylstannane 6 appeared at −187 ppm. We believe that tin chemical shifts are 
highly sensitive to oxygen bonding, and this is strong evidence in favor of the complexed 
intermediate.  
 
Allyltrichlorostannane additions to mono and disubstituted aldehydes 
The next step involved the reaction between chiral α-substituted aldehydes and allylstannane 
(R)-6 (Scheme 2). These substrates have been selected to be representative of the complex 
fragments that might be coupled in polyacetate and polypropionate-derived aldol-type 
reactions.11
The in situ prepared allylstannane (R)-6 reacted with aldehyde (R)-7 to give a mixture of 1,4-
syn and 1,4-anti-diastereomers with 92:08 diastereoselectivity, favoring the 1,4-syn-isomer 8 
with Felkin addition (Scheme 2).11,12 It should be noted that this reaction gives a very important 
subunit with different protecting groups at both termini and a double bond that can be further 
manipulated to a carbonyl group and then selectively reduced to the 1,3-syn and 1,3-anti diol 
functionalities.  
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Under the same conditions, allyltrichlorostannane (R)- 6 reacted with aldehyde (S)-7 to give 





































The stereoselectivity of the reactions of allyltrichlorostannane (R)-6 with aldehydes (R)-7 and 
(S)-7 is consistent with an intermediate allyltin trichloride, which is stabilized by tin-oxygen 
interaction. A boat-like arrangement is proposed, as it avoids steric interactions between the 
aldehyde substituents and the axial methyl group α to the double bond in the chair structure 
(transition states A, Scheme 2 and B, Scheme 3). This complex intermediate then reacts with the 
aldehyde via chair-like six-membered ring transition states (A and B) in which the aldehyde 
approaches the complex opposite to the methyl group. The preference of the alkyl group of the 
aldehyde to adopt an equatorial position controls the aldehyde facial selectivity, resulting in the 
favored 1,4-syn stereochemistry in the adduct, independent of the aldehyde absolute 
configuration.  
These examples shown that the levels of π-facial selection are independent of the absolute 
stereochemistry of the α-methyl substituted aldehydes and support the notion that the 
stereocenter in allyltrichlorostannane is primarily responsible for the observed 
diastereoselection.6
We investigated the reaction between chiral β-alkoxy as well as α-methyl-β-alkoxy 
aldehydes with achiral and chiral allyltrichlorostannanes.13 This study details our efforts to 
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understand the double stereodifferentiating stereocontrol elements involved in chiral 
allyltrichlorostannane additions to chiral β- and α,β-disubstituted aldehydes. In this part of the 
investigation, we have examined the interplay between 1,2- (Felkin-Anh), 1,3- and 1,4-
asymmetric induction in allyltrichlorostannane reactions with β-alkoxy and α-methyl-β-alkoxy 
aldehydes under conditions that preclude internal chelation with the aldehyde β-alkoxy 
substituent. 
In order to check the facial selectivity of aldehyde (S)-10 we reacted it first with achiral 






























Achiral allyltrichlorostannane 4 reacted with chiral β-alkoxy aldehyde (S)-10 in CH2Cl2 at –
78 oC to give the corresponding 1,3-anti product 11 as the major product in good yield and with 
78:22 diastereoselectivity (Scheme 4).13 The stereoinduction observed in this reaction indicates 
that the intrinsic facial bias imposed by the resident β-OTBS substituent results in preferential 
formation of the 1,3-anti diastereomer, with a preference for aldehyde si-face attack. In the 
proposed transition state conformation (C), steric interactions are expected to be reduced when 
the β-Me substituent in this aldehyde is placed anti to the Cα-C=O bond (Scheme 4). In this 
conformation we might expect also minimization of destabilizing dipole interactions since the β-
OTBS group and C=O are oriented in opposite directions. A chair-like transition state (C) with 
the alkyl group of the aldehyde in an equatorial position and with attack to the si-face of the 
aldehyde, explains the observed sense of induction. 
Under the same conditions allyltrichlorostannane (S)-6 reacted with aldehyde (S)-10 to give 
1,3-anti-1,4-syn product 12 as the major product (85:15 diastereoselectivity) (Scheme 5).13  As 
we know from previous work that the facial bias of this chiral allyltrichlorostannane is 
dominated by the α-methyl stereocenter and tends to give the 1,4-syn isomer with si-face attack, 
and aldehyde (S)-10 has a preference to give the 1,3-anti product, this is an example of a 
matched reaction.  
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The stereoselectivity of this reaction is consistent with an intermediate allyltin trichloride 
which is stabilized by tin-oxygen interaction, and which then reacts with the aldehyde via a 
chair-like six-member ring transition state (D) in which the aldehyde approaches the boat-like 
complex opposite to the methyl group (Scheme 5). Again, a boat-like arrangement is proposed, 
as it avoids steric interactions between the aldehyde substituents and the axial methyl group α to 
the double bond in the chair structure.  
Addition of the enantiomeric allyltrichlorostannane (R)-6 to aldehyde (S)-10 led to a 67:33 
mixture favoring the 1,4-syn-1,3-syn product 13, in a mismatched case (Scheme 5).13 
We next examined the stereochemical impact of both α and β-aldehyde substituents using chiral-
syn and anti disubstituted α-methyl-β-alkoxy aldehydes. 13-15
Achiral allyltrichlorostannane 4 reacted with chiral syn-α,β-disubstituted14 aldehyde 14  to give 






























ISSN 1551-7012 Page 245 ©ARKAT USA, Inc 
 
Issue in Honor of Prof. R. Rossi and Prof. E. Rúveda ARKIVOC 2003 (x) 240-261 
 
This example shows that a 1,2-syn aldehyde has a preference to give the product with Felkin 
addition as well as 1,3-syn addition.13 In the presence of an α-methyl stereocenter, 1,3-
asymmetric induction imposes an intrinsic facial bias on the carbonyl that results in the 
formation of the 1,3-syn-dioxygen relationship.  
A chair-like transition state (E) with attack to the re-face of the aldehyde (Felkin addition), 
explains the observed induction direction (Scheme 6).
The reaction of chiral allyltrichlorostannane (R)-6 with aldehyde 16 gives homoallylic 
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diastereoselectivity












The stereoselectivity of this reaction is consistent with a chair-like six-membered ring 
transition state (F) in which the aldehyde approaches the boat-like allyltin complex opposite to 
the methyl group (Scheme 7).  
Allyltrichlorostannane (S)-6 reacted with aldehyde 16 to give a 70:30 ratio favoring isomer 
18, in a mismatched case (Scheme 7). In this latter case, the α-methyl stereocenter in 
allyltrichlorostannane (propensity for 1,4-syn addition) exerts a dominant influence on aldehyde 
facial selectivity, by overriding the intrinsic bias imposed by the α and β stereocenters in the 
aldehyde, to give the 1,3-syn product. 
Before starting the study described in Scheme 8, we expected that, under conditions that 
preclude internal chelation, the carbonyl facial bias of anti-disubstituted aldehyde 19 should be 
highly predictable, since the factors which favors both 1,2- and 1,3-asymmetric induction 
mutually reinforce nucleophilic addition to give 1,2-syn-1,3-anti diastereomer.16 We have 
observed that this is not the case under the reaction conditions described here. 
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Achiral allyltrichlorostannane 4 additions to chiral anti-α,β-disubstituted aldehyde 19 gave the 
corresponding 1,2-syn-1,3-anti-product 20 as the major product in good yields, although with 













































This example shows that an anti aldehyde has no facial preference under these conditions, 
since the Felkin addition to give 1,2-syn isomer competes with the β-alkoxy stereocenter to give 
the 1,3-syn isomer. We believe that in this case, the corresponding transition states should be 
very similar in energy, with conformer G (which gives the 1,2-syn isomer) being destabilized by 
the gauche interaction iPr/Me while conformer H (which gives the 1,2-anti isomer) being 
destabilized by the iPr/C=O and Me/OTBS gauche interactions (Scheme 8). 
Under the same conditions described before allyltrichlorostannane (S)-6 reacted with 
aldehyde 19 to give 1,2-syn-1,3-anti isomer 22 with 92:8 diastereoselectivity (Scheme 9).13 
The reaction of allyltrichlorostannane (R)-6 with aldehyde 19 gave homoallylic alcohol 23 as 
the major isomer in 88:12 diastereoselectivity (anti-Felkin addition, partially matched case).
The results described in Scheme 9 can be rationalized with dominant acyclic 1,4-asymmetric 
induction from the chiral allyltrichlorostannane. These are examples of partially matched 
reactions, with the chiral allyltrichlorostannanes (R)-6 and (S)-6 being responsible for the control 
of the observed diastereoselectivities, through transition states analogous to I and J, respectively 
(Scheme 9). Poor levels of diastereoselectivity characterize this reaction with 1,2-anti β-OTBS 
aldehydes only when an achiral allyltrichlorostannane is used. This attenuated 1,3-anti selectivity 
for 1,2-anti aldehydes with the TBS protecting group appears to be general, as similar trends 
were observed for titanium and boron aldol reaction variants.16 One might project that the 
transition states of these reactions exhibit less charge separation than the aldol processes, and are 
accordingly less subject to the electrostatic influence of the β-OTBS function. 
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The examples presented in this work show that the levels of π-facial selection are dependent 
on the absolute stereochemistries of the disubstituted aldehydes as well as of the 
allyltrichlorostannane. 
The results from these experiments suggest that the stereochemical relationships between the 
α and β aldehyde substituents may confer either a reinforcing (matched) or opposing 
(mismatched) facial bias on the carbonyl moiety. In this complex scenario, the chiral 
allyltrichlorostannane may adopt either a reinforcing or opposing relationship. One possible 
reason for this result could be attributed to the involvement of energetically similar chair and 
twist-boat pericyclic transition states which lead to diastereomeric product formation. Another 
possibility to consider in these reactions is that nonbonded interactions between the 
allyltrichlorostannane and aldehyde α substituents may not be significant in pericyclic transition 
states leading to either Felkin or anti-Felkin addition products.13-17 
 
Allyltrichlorostannane additions to α-aminoaldehydes 
In recent years there has been a major research effort towards the development of clinically 
useful inhibitors of aspartyl proteases.18-21 This worldwide search has led to various peptide 
isosteres, wherein the scissile peptide bond is replaced by a hydrolytically more stable isosteric 
functional group. In this context, the hydroxyl amino acid framework II in Figure 3, where the 
peptidic linkage of the sequence in structure I is replaced by a CH(OH)CH2 group, constitutes a 
useful class of aspartyl protease inhibitors. 
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We were interested to investigate the allyltrichlorostannane additions to chiral aldehydes 24. 
In order to confirm the facial selectivities of the (S)-N-Boc-α-aminoaldehydes 24, we reacted 















  -780C ++
1,2-syn                   1,2-anti
25a-c 26a-c
2
(S)-24a, R = Me
(S)-24b, R = Bn
(S)-24c, R = iPr
R = Me 88:12 (85%)
R = Bn 90:10 (86%)




In all cases, the major product results from a chelation controlled reaction that mainly gives 
the 1,2-syn isomers 25a-c, showing that the (S)-α−aminoaldehydes 24a-c have a preference for 
anti-Felkin addition (si face attack).22  
Under the same conditions, chiral allyltrichlorostannane (S)-6 reacted with (S)-α-
aminoaldehydes 24 to give a mixture of 1,2-syn 25 and 1,2-anti 26 diastereomers with useful 
diastereoselectivities, favoring the 1,2-syn-isomer with anti-Felkin addition and aldehyde si face 


























anti-Felkin  addition  Felkin addition
CH2Cl2
-78°C
R = Me 95:05 (88%)
R = Bn 95:05 (84%)
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As we are aware from previous work that the chiral allyltrichlorostannane (S)-6 has a 
preference for si face approach, this is an example of a matched reaction.  It should be noted that 
this reaction gives a very important subunit with a double bond and a benzyl protected primary 
alcohol that can be further manipulated.  
A synthetic methodology, which allows compounds with programmed variations of 
substituents to be synthesized, is particularly important in the screening of the pharmacological 
activity and in a study of structure-activity relationships directed toward the design of the best 
substituents for positions 1 and 4 in structure III (R and R1 groups in Figure 3).  
Towards this end we initiated a study towards the synthesis of more complex dipeptide 
isosteres by reaction of allyltrichlorostannanes with dipeptide aldehydes.23,24 The present 
methodology is useful for the preparation of molecules of type III and consists in the first step in 
the preparation of molecules of type II (Figure 3). To the best of our knowledge, these were the 
first examples of successfully allylsilane additions to chiral dipeptide aldehydes. 
The results of allyltrichlorostannane additions to dipeptide aldehydes 27a-f are shown in Scheme 12. In 
all cases, the major product results from a chelation controlled reaction that mainly gives the 1,2-syn isomer, 
showing that the (S)-α-amino dipeptide aldehydes have a preference for anti-Felkin addition (si face attack). 
Increased steric bulk of the R2 group (R2 = iPr, iBu)  in the aldehydes gives better diastereoselection. With 
small R2 groups (R2 = Me, Bn, CH2OTBS) the diastereoselectivity is poor, although the reaction occurs in 
very good yields. It is essential to promote the ligand exchange reaction before addition of the aldehyde in 






























   1,2-syn
28a-f, R = H
30a-f, R = Bn2, R = H
4, R = Bn
+
   1,2-anti
29a-f, R = H
31a-f, R = Bn
+




Dipeptide Aldehydes 27 
 
 
R = H 
 
R = Bn 
R1 R2 28:29 Yield (%) 30:31 Yield (%) 
 Bn Me 78:22 87 68:32 80 
Bn iPr 95:05 89 95:05 89 
Bn iBu 90:10 83 90:10 83 
Bn Bn 60:40 79 60:40 70 
iPr Bn 53:47 74 60:40 75 
Bn CH2OTBS 66:34 86 60:40 74 
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Although the remote stereogenic center may influence the stereochemical course of C-C 
bond formation, we expect such reactions to be dominated by the stereogenic center next to the 
aldehyde function. We believe that the observed selectivity can be explained by an equilibrium 
between the intramolecular hydrogen bond conformer (K) and a not bonded conformer (L) 
(Figure 4).22,23 When the form K predominates (bulkier R groups), the syn isomer is favored 
whereas the prevalence of the L-like conformer (smaller R groups) leads to the anti isomer. The 
nucleophile selects the less hindered si-face forming a six membered transition state M where the 



























We have applied this protocol to the synthesis of tripeptide 36 (Scheme 13). Acetonide 
formation from 28b followed by hydroboration with BH3-THF followed by Dess-Martin and 
Pinnick oxidation gave carboxylic acid 33 in 44% overall yield. Coupling of 33 with 34 using 
standard conditions gave 35 that was treated with the complex BF3-2AcOH in MeOH to give 




























































Total synthesis of aspartyl protease inhibitors 
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Based on our initial results on allyltrichlorostannane additions to N-Boc-α-aminoaldehydes and 
attracted by the HIV inhibitory potency of L685,434 (37), L-682,679 (38) as well as by the 
highly potent inhibition of AβPP γ-secretase activity of L-685,458 (39), we initiated a project 
directed towards their total synthesis (Figure 5). The approach described here to L685,434 (37), 
L-682,679 (38), and L-685,458 (39) might also give access to additional derivatives with 
























- Originally developed as an HIV  protease inhibitor
- Poor inhibitor of HIV protease but a potent inhibitor 
of γ-secretase









     L-685,434
 ( IC50= 0,23 nM)
   








Addition of the aldehyde 24b to a CH2Cl2 solution of allyltrichlorostannane 4 at −78oC gave 


















Direct hydroboration of the unprotected homoallylic alcohol 40 with BH3.DMS in THF at 
0oC gave a mixture of diols 41 and 42, in 93% yield (Scheme 15). 
These diols were not separated but were converted directly to a mixture of lactones 43 and 44 
(95% yield) by treatment with TPAP and NMO in the presence of molecular sieves at room 
temperature.31,32 These lactones were readily separated by flash column chromatography. 
Although these lactones have been prepared earlier by others, the relative stereochemistry for 
cis-lactone 44 was ascertained by NOESY experiments (observed interaction between Ha and 
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Hb). Attempts to obtain more of the desired trans-lactone 43 by a deprotonation and 
reprotonation sequence of cis-lactone 44 led to a 70:30 mixture of lactones 43:44 in 96% yield 
(Scheme 15). It is interesting to point out that cis-lactone 44 is also an important intermediate for 





































Basic hydrolysis of desired trans-lactone 43 (LiOH, 1,2-dimethoxyethane), silylation 
(TBSCl, imidazole, DMF, room temperature, 12h) of the resulting carboxylate, and selective 
desilylation of the acylsiloxy moiety (MeOH) cleanly provided 45 in excellent yield after 
purification by silica-gel flash chromatography (Scheme 16).  
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Compound L-685,434 (37) was readily prepared from carboxylic acid 45 by a simple peptide 
coupling reaction with 1(S)-amino-2(R)-hydroxyindane 34 followed by TBS removal with TBAF 
in 70% yield for the 2-step sequence (Scheme 16). 
Compound L-682,679 (38) is also prepared from carboxylic acid 45 and dipeptidic amine NH2-
Leu-Phe-NH2 by a simple peptide coupling reaction followed by TBS deprotection with TBAF 
in 86% overall yield (Scheme 17).31,32 
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382. TBAF, THF r.t., 94%
PDC, DMF
 r.t., 85%   LiBH4
EtOH, -60oC     












Oxidation of the hydroxyl function in 38 with PDC in DMF gave inhibitor L-684,414 (46) in 
85% isolated yield. Selective reduction of L-684,414 (46) with LiBH4 gave γ-secretase inhibitor 





We believe that this chemistry is truly significant in the context of acyclic diastereoselection and 
will prove to be useful in the synthesis of more complex molecules like polyacetate and 
polypropionate-derived natural products as well as in the synthesis of a variety of dipeptide 





General Procedures. All reactions were carried out under an atmosphere of argon or nitrogen in 
flame-dried glassware with magnetic stirring. Dichloromethane, triethylamine, cyclohexane, and 
dimethylformamide were distilled from CaH2. Tin tetrachloride was distilled from P2O5 and 
stored in a Schlenk flask. Dimethyl sulfoxide was distilled under reduced pressure from calcium 
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hydride and stored over molecular sieves. THF, diethyl ether and toluene were distilled from 
sodium/benzophenone ketyl. Oxalyl chloride, dimethoxypropane, isobutyraldehyde, 
trimethylsilylmethyl chloride and (c-Hex)2BCl were distilled immediately prior to use. MeOH 
was distilled from Mg(OMe)2. TLC plates were silica gel 60 (GF 5-40-µm). Visualization was 
accomplished with either a UV lamp or I2 staining. Chromatography on silica-gel (230-400mesh) 
was performed using forced-flow of the indicated solvent system (flash chromatography). 
Visualization was accomplished with UV light and an anisaldehyde, ceric ammonium nitrate 
stain, a heated phosphomolybdic acid or by I2 staining. 1H NMR spectra were recorded on either 
a Varian Gemini 300 (300MHz) or a Varian Inova 500 (500MHz) spectrometer and are reported 
in ppm using solvent as an internal standard (CDCl3 at 7.26 ppm or C6D6 at 7.15 ppm) unless 
otherwise indicated. Data are reported as (ap = apparent, s = singlet, d = doublet, t = triplet, q = 
quartet, qt = quintet, st = sextet, apt = apparent triplet, m = multiplet, b = broad, brs = broad 
singlet, brd = broad doublet, dq = doublet of quartets, dt = doublet of triplets, td = triplet of 
doublets, apqt = apparent quintet, apdt = apparent doublet of triplets, number of hydrogens, 
coupling constant(s) in Hz. Proton-decoupled 13C NMR spectra were recorded on either a Varian 
Gemini 300 (75 MHz) or Bruker AC 300/P (75 MHz) spectrometers and are recorded in ppm 
using solvent as an internal standard (CDCl3 at 77.0 ppm or C6D6 at 128 ppm) unless otherwise 
indicated. Infrared spectra were recorded on a Perkin-Elmer 1600 FTIR spectrophotometer. Mass 
spectra were recorded on a HP-5988-A GC-MS. Optical rotations were measured on a Polamat A 
polarimeter from Carl Zeiss Jen, using a 1 mL quartz cell, with mercury or sodium lamps, and 
are reported as follows: [a]t(oC)λ, (c g/100mL, solvent). 
 
General procedure for the preparation of homoallylic alcohols 11-13, 15, 17, 20-22-23 
To a solution of allylsilane 5 (1.5 mmol) in CH2Cl2 (5 mL) at 0 °C was added SnCl4 (1.5 mmol). 
The resulting solution was stirred at 0 °C for 5 min and then cooled to –78 °C when a solution of 
the corresponding aldehyde (1.5 mmol) in CH2Cl2 (2 mL) was added. This mixture was stirred 
for 2 h at –78 °C and quenched by the slow addition of a saturated aqueous solution of NaHCO3 
(5 mL) followed by CH2Cl2 (10 mL). The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x 5 mL). The combined organic layer was dried (MgSO4), filtered, and 
concentrated in vacuo. Purification by flash chromatography on silica gel (10% EtOAc/hexane) 
gave the corresponding homoallylic alcohols. 
(2S,4S)-6-Benzyl-2-[tert-butyl(dimethyl)silyloxy]-6-octen-4-ol (11). TLC: Rf 0.20 (5% 
EtOAc/hexanes); 1H NMR (CDCl3, 300 MHz): δ 0.10 (s, 3H), 0.11 (s, 3H), 0.92 (s, 9H), 1.17 (d, 
J 6.2 Hz, minor isomer) + 1.20 (d, 3H, J 6.2 Hz), 1.45-1.63 (m, 2H), 2.04-2.26 (m, 2H), 3.39 (s, 
2H), 3.86-4.06 + 4.08-4.26 (m, 2H), 4.88 (s, 1H), 4.94 (s, 1H), 7.16-7.34 (m, 5H); 13C NMR 
(CDCl3, 75 MHz): δ -4.8, -4.6, -4.3, -3.8, 18.0, 18.1, 23.3, 24.5, 25.9, 43.1, 43.2, 44.0, 44.1, 44.6, 
45.5, 65.9, 67.1, 68.9, 69.6, 113.9, 114.0, 126.0, 128.2, 128.9, 139.2, 145.6, 145.8. 
(2S,4S)-6-[(S)-2-Benzyloxy-1-methylethyl]-2-[tert-butyl(dimethyl)silyloxy]-6-hepten-4-ol 
(12). TLC: Rf 0.22 (10% EtOAc/hexanes); 1H NMR (CDCl3, 300 MHz): δ 0.08 (s, 3H), 0.09 (s, 
3H), 0.91 (s, 9H), 1.05 (d, 3H, J 7.0 Hz), 1.19 (d, 3H, J 6.2 Hz), 1.58 (m, 2H), 2.18 (d, 2H, J 5.5 
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Hz), 2.49 (m, 1H), 3.23 (br s, 1H), 3.37 (dd, 1H, J 9.2 and 6.4 Hz), 3.49 (dd, 1H, J 9.2 and 7.7 
Hz), 4.08 (m, 1H), 4.15 (m, 1H), 4.52 (s, 2H), 4.93 (s, 2H), 7.25-7.40 (m, 5H); 13C NMR 
(CDCl3, 75 MHz): δ -4.8, -4.3, 17.6, 18.1, 23.8, 26.0, 39.2, 44.4, 45.3, 65.9, 66.6, 73.1, 74.7, 
111.7, 127.5, 127.6, 128.2, 138.1, 149.1. 
(2S,4R)-6-[(R)-2-Benzyloxy-1-methylethyl]-2-[tert-butyl(dimethyl)silyloxy]-6-hepten-4-ol 
(13). TLC: Rf 0.24 (10% EtOAc/hexanes); 1H NMR (CDCl3, 300 MHz): δ 0.09 + 0.10 + 0.11 + 
0.12 (s, 6H), 0.90 (s) + 0.91 (s, 9H), 1.07 (d, J 7.0 Hz) + 1.10 (d, 3H, J 7.0 Hz), 1.18 (d,  J 5.9 Hz) 
+ 1.20 (d, 3H, J 6.2 Hz), 1.50-1.65 (m, 2H), 2.16-2.24 (m, 2H), 2.49 (m, 1H), 3.30-3.45 (m, 2H), 
3.51 (m, 1H), 3.90-4.22 (m, 2H), 4.52 (s, 2H), 4.93 (s, 2H), 7.25-7.40 (m, 5H); 13C NMR (CDCl3, 
75 MHz): δ -4.6, -3.9, 17.5, 18.1, 23.5, 24.3, 25.9, 29.8, 39.2, 43.9, 44.2, 45.1, 45.7, 66.5, 66.8, 
68.3, 68.8, 71.1, 73.0, 74.6, 74.7, 111.7, 111.8, 125.9, 126.3, 127.5, 128.7, 130.2, 138.2, 148.8, 
149.0. 
(4R,5S,6S)-2-Benzyl-6-O-tert-butyldimethylsilyloxy-5,7-dimethyl-1-octen-4-ol (15). TLC Rf: 
0.48 (10% EtOAc/hexanes); [α]20D: +5.0 (c 2.18, EtOAc); 1H RMN (CDCl3, 300 MHz): δ 0.13 
(s, 6H), 0.92 (d, 3H, J 7.0 Hz), 0.97 (br s, 15H, J 5.5 Hz), 1.69 (m, 1H), 1.89 (m, 1H), 1.96 (br s, 
1H), 2.22 (d, 2H, J 6.6 Hz), 3.45 (br s, 2H), 3.58 (t, 1H, J 3.7 Hz), 3.85 (br s, 1H), 4.96 (br s, 
1H), 5.02 (br s, 1H), 7.25-7.39 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ -3.6, -3.1, 9.6, 18.6, 18.8, 
19.6, 26.5, 33.1, 40.5, 42.2, 43.4, 71.9, 79.8, 114.8, 126.7, 128.8, 129.4, 139.7, 146.6; IR (film): 
ν 3571, 3480, 3063, 3027, 3480, 2959, 2922, 2858, 1645, 1602, 1496, 1471, 1259, 1091, 1027, 
826 cm-1. 
(2S,3R,4R)-6-[(1R)-2-Benzyloxy-1-methylethyl]-3-methyl-6-hepten-2,4-diol (17). TLC Rf: 
0.40 (10% EtOAc/hexanes); [α]D: + 20.7 (c 0.42, CHCl3); 1H NMR (CDCl3, 300 MHz): δ 0.07 
(s, 3H), 0.08 (s, 3H), 0.87 (d, 3 H, J 6.8 Hz), 0.91 (d, 3H, J 6.3 Hz), 0.92 (s, 9H), 0.94 (d, 3H, J 
6.8 Hz), 1.04 (d, 3H, J 6.8 Hz), 1.67 (m, 1H), 1.84 (m, 1H), 2.15 (dd, 1H, J 9.4 and 14.0 Hz), 
2.23 (dd, 1H, J 3.7 and 13.9 Hz), 2.47 (m, 1H), 3.37 (dd, 1H, J 6.1 and 9.0 Hz), 3.48 (dd, 1H, J 
8.1 and 9.0 Hz), 3.55 (t, 1H, J 4.1 Hz), 3.81 (m, 1H), 4.50 (s, 2H), 4.94 (s, 1H), 4.95 (s, 1H), 
7.26–7.36 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ -3.9, -3.6, 9.8, 17.6, 18.1, 18.4, 19.5, 26.1, 
32.6, 39.0, 40.6, 41.7, 71.0, 73.1, 74.6, 78.9, 111.9, 127.6, 127.7, 128.3, 138.1, 149.4;  IR (film): 
ν 3471, 3065, 3025, 2963, 2922, 2854, 1641, 1464, 1258, 1105, 1047, 841, 773, 738, 698 cm-1; 
HRMS Calcd. for C26H46O3Si: 434,3216; found: 373.2499; MS (70 eV): m/z: 373 (3%), 305 
(2%), 269 (5%), 245 (9%), 223 (4%), 187 (77%), 147 (43%), 115 (7%), 91 (100%). 
(3S,4R,5S)-7-[(S)-2-Benzyloxy-1-methylethyl]-3-[tert-butyl(dimethyl)silyloxy]-2,4-dimethyl-
7-octen-5-ol (22). TLC: Rf 0.20 (5% EtOAc/hexanes); 1H NMR (CDCl3, 300 MHz): δ 0.11 (s, 
3H), 0.13 (s, 3H), 0.91 (d, 3H, J 7.0 Hz), 0.93 (d, 3H, J 6.6 Hz), 0.94 (s, 9H), 0.99 (d, 3H, J 7.0 
Hz), 1.10 (d, 3H, J 7.0 Hz), 1.70 (ddd, 1H, J 7.0, 3.7 and 1.8 Hz), 1.92 (m, 1H), 2.13 (dd, 1H, J 
14.0 and 6.0 Hz), 2.29 (dd, 1H, J 14.0 and 7.7 Hz,), 2.49 (m, 1H), 3.30 (s, 1H), 3.33 (m, 1H), 
3.48 (dd, 1H, J 6.2 and 3.7 Hz), 3.53 (dd, 1H, J 9.2 and 5.9 Hz,), 4.25 (ddd, 1H, J 7.7, 6.2 and 
1.8 Hz), 4.52 (s, 2H), 4.91 (s, 1H), 4.95 (s, 1H), 7.20-7.40 (m, 5H); 13C NMR (CDCl3, 75 MHz): 
δ -3.6, -3.5, 11.8, 17.4, 18.5, 19.1, 19.9, 26.3, 32.2, 38.0, 39.3, 41.0, 68.7, 73.0, 74.7, 83.1, 111.3, 
127.3, 127.5, 128.2, 138.3, 148.9. 
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(3S,4R,5R)-7-[(R)-2-Benzyloxy-1-methylethyl]-3-[tert-butyl(dimethyl)silyloxy]-2,4-dimethyl-
7-octen-5-ol (23). TLC: Rf 0.24 (5% EtOAc/hexanes); 1H NMR (CDCl3, 300 MHz): δ 0.09 (s, 
3H), 0.10 (s, 3H), 0.91 (d, 3H, J 7.0 Hz), 0.92 (d, 3H, J 6.6 Hz), 0.93 (d, 3H, J 7.0 Hz), 0.94 (s, 
9H), 1.08 (d, 3H, J 7.0 Hz), 1.75-1.90 (m, 2H), 2.00 (dd, 1H, J 14.3 and 10.3 Hz), 2.42 (br d, 1H, 
J 14.3 Hz), 2.50 (m, 1H), 2.55 (brs, 1H), 3.40 (dd, 1H, J 9.0 and 6.6 Hz), 3.53 (dd, 1H, J 9.0 and 
7.5 Hz), 3.60 (ap t, 1H, J 4.6 Hz), 3.76 (ddd, 1H, J 10.3, 8.4 and 2.6 Hz), 4.52 (s, 2H), 4.94 (s, 
1H), 4.98 (s, 1H), 7.25-7.40 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ  -4.1, -3.7, 14.1, 17.9, 18.4, 
18.5, 20.6, 26.2, 32.1, 39.0, 41.4, 43.2, 70.6, 73.0, 74.7, 79.8, 111.4, 127.4, 127.5, 128.2, 138.1, 
149.4. 
 
General procedure for the preparation of homoallylic alcohols 28a-c-30b-c 
To a solution of allylsilane (1.5 mmol) in CH2Cl2 (5 mL) at r.t. was added SnCl4 (1.4 mmol). The 
resulting solution was stirred at rt for 2 h and then cooled to –78 °C when a solution of the 
corresponding aldehyde (1.4 mmol) in CH2Cl2 (2 mL) was added. This mixture was stirred for 2 
h at –78 °C and quenched by the slow addition of a saturated aqueous solution of NaHCO3 (5 
mL) followed by CH2Cl2 (5 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2 x 5 mL). The combined organic layer was dried (MgSO4), filtered, and 
concentrated in vacuo. Purification by flash chromatography on silica gel (20-30% 
EtOAc/hexane) gave the corresponding homoallylic alcohols. 
(4S,5S)-5-[N-(tert-Butoxycarbonyl-(S)-phenylalanyl)amino]-1-hexenyl-4-ol (28a). TLC: Rf 
0.21 (35% EtOAc/hexane); mp 100.3-101.9 oC; [α]20D: -17.8 (c 0.5, CHCl3); 
1H NMR (CDCl3, 
300 MHz): δ 0.96 (d, J 6.9 Hz, minor isomer) and 1.06 (d, 3H, J 6.9 Hz), 1.39 (s, 9H), 1.84 (m, 
1H, minor isomer), 1.96 (m, 2H), 2.52 (br s, 1H), 2.97 (d, 2H, J 6.9 Hz), 3.41 (m, 1H), 3.84 (m, 
1H), 4.26 (m, 1H), 5.02 (m, 2H), 5.18 (m, 1H), 5.60 (m, 1H), 6.22 (m, minor isomer) and 6.29 
(m, 1H), 7.13-7.24 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ 13.5 (minor isomer), 17.8, 28.2, 38.4 
(minor isomer), 38.5, 48.6, 49.0 (minor isomer), 56.0, 72.5 (minor isomer), 72.9, 80.1, 117.6 
(minor isomer), 117.9, 126.8, 128.5, 129.3, 134.4 (minor isomer), 136.6, 155.4, 170.7, 171.1; IR 
(KBr): ν 3351, 3072, 2980, 1682, 1641, 1549, 1520, 1457, 1369, 1293, 1247, 1165, 987, 755, 
703 cm-1; Elemental analysis calcd. for C20H30N2O4: C 66.27,H 8.34, N 7.73, found: C 65.60; H 
8.17, N 7.74; HRMS calcd. for C20H30N2O4: 362.2206;  found: 362.2206. 
(4S,5S)-5-[N-(tert-Butoxycarbonyl-(S)-phenylalanyl)amino]-6-methyl-1-heptenyl-4-ol (28b). 
TLC: Rf 0.22 (35% EtOAc/hexane); mp148.6-150.8 oC; [α]20D: -40,0 (c 1.0, CH2Cl2); 1H NMR 
(CDCl3, 300 MHz): δ 0.84 (d, 3H, J 6.9 Hz), 0.93 (d, 3H, J 6.6 Hz), 1.41 (s, 9H), 1.83 (m, 2H), 
1.93 (m, 1H), 3.08 (m, 2H), 3.46 (ap t, 1H), 3.76 (m, 1 H), 4.35 (ap q, 1H, J 7.3 Hz), 5.10 (m, 
2H), 5.18 (br d, 1H, J 8,8 Hz), 5.75 (m, 1H), 6.32 (br d, J 9,5 Hz), 7.18-7.31 (m, 5H); 13C NMR 
(CDCl3, 75 MHz): δ 19.3 19.7, 28.2, 30.0, 37.9, 39.2, 56.3, 58.1, 69.4, 80.2, 118.2, 126.9, 128.6, 
129.3, 134.0, 136.6, 155.0, 171.6; IR (KBr): ν 3345, 3078, 2963, 2933, 1682, 1635, 1549, 1514, 
1422, 1369, 1299, 1165, 1038, 703 cm -1; HRMS calcd. 390.2519; found:390.2512. 
(4S,5S) 5-[N-(tert-Butoxycarbonyl -(S) -phenylalanyl) amino]7methyl1octenyl4-ol (28c). TLC: Rf 0.23 
ISSN 1551-7012 Page 258 ©ARKAT USA, Inc 
 
Issue in Honor of Prof. R. Rossi and Prof. E. Rúveda ARKIVOC 2003 (x) 240-261 
(35% EtOAc/hexane); mp 143.8-145.2 oC; [α]20D: -34.0 (c 1.0, EtOH); 1H NMR (CDCl3, 300 MHz): δ 
0.87 (d, 3H, J 6.6 Hz), 0.90 (d, 3H, J 6.6 Hz), 1.37 (m, 2H), 1.42 (s, 9H), 1.87 (m, 1H), 2.07 (br s, 2H), 3.09 
(br d, 2H, J 6.2 Hz), 3.53 (m, 1H), 3.92 (m, 1H), 4.32 (ap q, 1H, J 7.3 Hz), 5.02 (m, 2H), 5.14 (br s, 1H), 
5.77 (m, 1H), 6.06 (d, 1H, J 9.5 Hz), 7.18-7.33 (m, 5H); 13C NMR (CDCl3, 75 MHz): δ 22.0, 23.2, 24.5, 
28.2, 37.7, 38.8, 41.5, 50.8, 56.2, 72.2, 80.3, 118.2, 126.9, 128.7, 129.3, 134.5, 136.6, 155.4, 171.1; IR 
(KBr): ν 3438, 3351, 3078, 2951, 1775, 1687, 1641, 1555, 1520, 1363, 1293, 1241, 1178, 1120, 
900, 870, 703 cm -1; Elemental analysis calcd. for C23H36N2O4: C 68.29, H 8.97, N 6.92; found: 
C 68.47, H 8.97, N 6.92; HRMS calcd. for C23H36N2O4: 404.2675;  found: 404.2601. 
(4S,5S)-5-[N-(tert-Butoxycarbonyl-(S)-phenylalanyl)amino]-6-methyl-2-benzyl-1-heptenyl-
4-ol (30b). TLC: Rf 0.23 (35% EtOAc/hexane); mp 132.5-134.3 oC; [α]20D: -26.3 (c 0.76, 
CH2Cl2); 1H NMR (CDCl3, 300 MHz): δ 0.81 (d, 3H, J 6.6 Hz), 0.87 (d, 3H, J 6.6 Hz), 1.40 (s, 
9H), 1.76 (m, 2H), 1.87 (m, 2H), 3.05 (m, 2H), 3.31 (br d, 2H, J 3.7 Hz), 3.41 (ap t, 1H, J 8.8 
Hz), 3.74 (br d, 1H, J 7.7 Hz), 4.33 (ap q, 1H, J 7.3 Hz), 4.8 (br s, 1H), 4.87 (br s, 1H), 5.00 (br 
d, 1H, J 8.1 Hz), 6.20 (br d, 1H, J 9.5 Hz), 7.24 (m, 10H); 13C NMR (CDCl3, 75 MHz): δ 19.3, 
19.6, 28.2, 30.3, 37.9, 41.2, 42.8, 56.3, 58.2, 67.2, 80.2, 115.2, 126.3, 126.9, 128.4, 128.6, 128.9, 
129.3, 136.6, 138.9, 145.2, 155.4, 171.2; IR (KBr): ν 3351, 3084, 3031, 2974, 2933, 2869, 1682, 
1641, 1549, 1520, 1450, 1363, 1293, 1241, 1165, 1044, 870, 755, 703 cm -1; Elemental analysis 
calcd. for C29H40N2O4: C 72.47, H 8.39, N 5.83; found: C 71.37, H 8.42, N 5,95; HRMS calcd. 
for C29H40N2O4: 480.2988;  found: 480.2912. 
(4S,5S)-5-[N-(tert-butoxycarbonyl-(S)-phenylalanyl)amino]-7-methyl-2-benzyl-1-octenyl-4-
ol (30c). TLC: Rf 0.25 (35% EtOAc/hexane); mp 127.8-131.5 oC; [α]20D: -15.7 (c 0.6, CHCl3); 
1H NMR (CDCl3, 300 MHz): δ 0.85 (d, 3H, J 6.2 Hz), 0.88 (d, 3H, J 6.2 Hz), 1.42 (s, 9H), 1.80 
(m, 1H), 1.99 (m, 2H), 3.03 (d, 2H, J 7.3 Hz), 3.30 (ap q, 2H, J 8.2 Hz), 3.55 (br d, 1H, J 8.1 
Hz), 3.85 (m, 1H), 4.32 (ap q, 1H, J 6.6 Hz), 4.83 (br s, 1H), 4.85 (br s, 1H), 4.98 (br d, 1H, J 7.3 
Hz), 6.0 (br d, 1H, J 9.1 Hz), 7.16-7,30 (m, 10H); 13C NMR (CDCl3, 75 MHz): δ 22.1, 23.1, 
24.6, 28.2, 38.0, 40.7, 41.8, 42.7, 50.9, 56.1, 70.1, 80.2, 115.0, 126.3, 126.9, 128.4, 128.6, 128.9, 
129.3, 136.6, 138.9, 145.3, 155.3, 170.9; IR (KBr): ν 3348, 3062, 3022, 2974, 2918, 1655, 1500, 
1457, 1374, 1252, 1164, 1047, 740, 700 cm -1; Elemental analysis calcd. for C30H42N2O4: C 
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